{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1012745138",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1427672516"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1012745138",
  "code": "LD2D.4",
  "source": "http://id.who.int/icd/entity/1012745138",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Gorlin syndrome"
  },
  "definition": {
    "@language": "en",
    "@value": "Gorlin syndrome, also known as naevoid basal cell carcinoma syndrome (NBCCS), is a hereditary condition characterised by a wide range of developmental abnormalities (odontogenic keratocysts of the jaws, hyperkeratosis of palms and soles, skeletal abnormalities, intracranial ectopic calcifications, and facial dysmorphism) and a predisposition to develop malignant neoplasms (such as multiple basal cell carcinomas or medulloblastoma), and benign neoplasms in the jaw, heart, or ovaries."
  },
  "inclusion": [
    {
      "label": {
        "@language": "en",
        "@value": "Naevoid basal cell carcinoma syndrome"
      }
    }
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Gorlin syndrome"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Naevoid basal cell carcinoma syndrome"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "NBCCS - [Naevoid basal cell carcinoma syndrome]"
      }
    }
  ]
}